Metformin Terapia

Metformin, the active ingredient in Metformin Terapia, is a biguanide presented as an oral tablet for oral use. It is prescribed to improve blood glucose control in adults with type 2 diabetes mellitus and related insulin‑resistant conditions. GNH USA supplies Metformin Terapia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Terapia belongs to the biguanide class and is used to manage disorders of glucose metabolism. - Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. - Prediabetes (impaired glucose tolerance): helps delay progression to overt diabetes. - Polycystic ovary syndrome: improves insulin sensitivity and may regularise menstrual cycles.

Metformin Terapia may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools, especially at treatment initiation. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration in taste perception. - Loss of appetite: reduced desire to eat. - Vitamin B12 deficiency: possible decrease with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening buildup of lactic acid. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: abnormal liver enzymes or hepatitis. - Hypoglycaemia: when combined with other glucose‑lowering agents. - Acute pancreatitis: inflammation of the pancreas.

Before prescribing Metformin Terapia, clinicians should consider several safety factors. - Renal function: avoid or adjust dose in patients with impaired kidney function. - Hepatic disease: use with caution in those with liver impairment. - Cardiovascular status: monitor in patients with unstable heart failure. - Alcohol intake: limit consumption to reduce risk of lactic acidosis. - Pregnancy and lactation: assess risk‑benefit, as safety data are limited. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Metformin Terapia can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: can raise metformin plasma concentrations.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Diuretics (thiazides): can affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and electrolytes. - Alcohol: potentiates risk of lactic acidosis.